The next-generation proteomics platform powered by Olink™ Explore HT enables simultaneous analysis of thousands of proteins from a single sample
Now a test that offers new precision in prostate cancer detection
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
Subscribe To Our Newsletter & Stay Updated
